NCT06067438View on ClinicalTrials.gov

Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal Cancer

PHASE2RecruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

June 21, 2024

Primary Completion Date

August 30, 2026

Study Completion Date

August 30, 2026

Conditions
Atrial FibrillationEsophageal Carcinoma
Interventions
DRUG

Amiodarone Hydrochloride

Given IV and via feeding tube

OTHER

Saline

Given IV

Trial Locations (1)

97239

RECRUITING

OHSU Knight Cancer Institute, Portland

All Listed Sponsors
lead

OHSU Knight Cancer Institute

OTHER